Medical

SGS Showcases Pharmaceutical Testing and Quality Solutions at CPhI Milan 2026

Medical /

Baar (September 10, 2026) – SGS, the world’s leading testing, inspection and certification company, is delighted to announce its participation at CPhI Milan 2026, the leading trade show for the pharmaceutical industry, from October 6-8, 2026. This event brings together over 250 speakers, 62,000 attendees and 2,900 exhibitors to create a uniquely wide-ranging forum for

SGS Showcases Pharmaceutical Testing and Quality Solutions at CPhI Milan 2026 Read More »

SGS enhances bioanalytical capacity with Saint-Benoît laboratory expansion

Medical /

Baar (August 13, 2026) – SGS, the world’s leading testing, inspection and certification company, has expanded its Saint-Benoît laboratory, a strategic site dedicated to pharmaceutical bioanalysis and drug development for the pharmaceutical and biotechnology industries. Located near Poitiers, France, the laboratory has been recognized as a key player for more than 35 years, supporting clients

SGS enhances bioanalytical capacity with Saint-Benoît laboratory expansion Read More »

SGS Launches GMP-Compliant NMR Testing for the Pharmaceutical Industry in China

Medical /

Baar (May 5, 2025) – SGS, the world’s leading testing, inspection and certification company, has expanded its analytical capabilities for the Chinese pharmaceutical industry with the introduction of nuclear magnetic resonance (NMR) testing. This new service offers robust qualitative and quantitative analysis for both drug substances and drug products, ensuring the highest standards of identity,

SGS Launches GMP-Compliant NMR Testing for the Pharmaceutical Industry in China Read More »

SGS hosts a free webinar to strengthen antibody-drug conjugate development workflows

Medical /

Baar (March 27, 2026) – SGS, the world’s leading testing, inspection and certification company, is pleased to announce a complimentary webinar titled ‘Supporting ADC Development: From Cell Bank Characterization to Batch Release’, taking place on April 28, 2026. With demand for antibody-drug conjugates (ADCs) continuing to rise, developers face increasing expectations around analytical rigor, regulatory

SGS hosts a free webinar to strengthen antibody-drug conjugate development workflows Read More »

SGS hosts webinar on EU IVDR certification for in vitro diagnostic devices manufacturers

Connectivity, Medical /

Baar (March 19, 2026) – SGS, the world’s leading testing, inspection and certification company, is pleased to host a complimentary webinar, ‘A Step-by-Step Guide to EU IVDR Certification.’ Placing in vitro diagnostic (IVD) medical devices on the European Union market requires compliance with Regulation (EU) 2017/746, the In Vitro Diagnostic Regulation (IVDR). This regulation establishes

SGS hosts webinar on EU IVDR certification for in vitro diagnostic devices manufacturers Read More »

SGS receives regulatory approval to restart human ¹⁴C ADME trials

Medical /

Antwerp, Belgium (February 16, 2026) – SGS today announced it has received formal approval from the Belgian Federal Agency for Nuclear Control (FANC) to resume human ADME (Adsorption, Distribution, Metabolism and Excretion) studies using ¹⁴C-radiolabeled investigational products. The approval enables SGS to reintroduce ¹⁴C human ADME studies at its clinical pharmacology unit in Antwerp, reinstating

SGS receives regulatory approval to restart human ¹⁴C ADME trials Read More »

SGS partners with innovative start-up theblood to advance women’s health diagnostics

Medical /

Baar (February 12, 2026) – SGS, the world’s leading testing, inspection and certification company, has entered into a partnership with Berlin-based health tech startup, theblood, to support the development and validation of women’s health diagnostics based on menstrual blood. The collaboration is designed to open up a new, non-invasive pathway for female-specific health diagnostics by

SGS partners with innovative start-up theblood to advance women’s health diagnostics Read More »

USP 665 compliance webinar for the pharmaceutical and biopharmaceutical professionals

Medical /

Geneva (November 3, 2025) – SGS, the world’s leading testing, inspection and certification company, is pleased to announce its complimentary webinar, ‘USP665 in Practice: Addressing Industry Questions on Single-Use System Compliance’, taking place on November 20, 2025. This live session will feature a roundtable discussion hosted by SGS’s leading extractables and leachables (E&L) experts, joined

USP 665 compliance webinar for the pharmaceutical and biopharmaceutical professionals Read More »

SGS webinar on nitrosamine and genotoxic impurity management

Medical /

Geneva (October 6, 2025) – SGS, the world’s leading testing, inspection and certification company, is pleased to announce a complimentary webinar, ‘Ensuring Patient Safety: Analytical Strategies for Nitrosamines & Genotoxic Impurities’, on October 21, 2025. Nitrosamines and other genotoxic impurities present a significant challenge to the pharmaceutical industry, as even trace levels can pose serious

SGS webinar on nitrosamine and genotoxic impurity management Read More »

SGS to showcase expertise and integrated drug development services at CPhI Frankfurt 2025

Medical /

Geneva (October 3, 2025) – SGS, the world’s leading testing, inspection and certification company, will attend CPhI Frankfurt 2025, taking place October 28–30 at Messe Frankfurt, Germany. This flagship event gathers pharmaceutical professionals worldwide to explore the latest trends and innovations in drug development, manufacturing and supply chain management. At stand 5.0A102 in the Contract

SGS to showcase expertise and integrated drug development services at CPhI Frankfurt 2025 Read More »

Scroll to Top